04.19.21 -- How To Navigate Compliance With FDA's 21 CFR Part 11

04.19.21 -- How To Navigate Compliance With FDA's 21 CFR Part 11
 
CUE Biopharma CEO Dan Passeri, JD joins the
Business of Biotech to discuss the development of their Immuno-STAT platform for the selective targeting and alteration of T cells. Passeri shares how the CUE-100 series of candidates in its pipeline are being developed to address a scourge of HPV-related head, neck, and other cancers. Listen now and subscribe so you never miss an episode.
Featured Editorial
By Kyle Neuman, SAFE Identity
21 CFR Part 11, the FDA's regulation on electronic records and electronic signatures, causes sleepless nights for many quality control experts and directors of regulatory compliance at CROs and pharma companies. How can you ensure compliance with this regulation?

Related Keywords

United States ,Melvat Covington ,Kate Hammeke ,Debra Jendrasek ,Webinar Medidata ,Yves Massicotte ,Joan Sutphen Glowatz ,Stacy Weil ,Larae Bennett ,Dassault Systemes ,Ropack Pharma Solutions ,Case Study Catalyst Clinical Research ,Webinar Elligo Health Research ,Ciox Real World ,Ropack Pharma ,Catalyst Clinical ,Thermo Fisher ,Elligo Health ,Fast Track ,ஒன்றுபட்டது மாநிலங்களில் ,கேட் ம்மேக்கே ,ஐவ் மாசிகோட் ,வழக்கு படிப்பு வினையூக்கி மருத்துவ ஆராய்ச்சி ,சிோக்ஷ ரியல் உலகம் ,வினையூக்கி மருத்துவ ,தெர்மோ மீனவர் ,வேகமாக டிராக் ,